Mast cell stabilizer modulates Sirt1/Nrf2/TNF pathway and inhibits oxidative stress, inflammation, and apoptosis in rat model of cyclophosphamide hepatotoxicity

References

• Adikwu E, Bokolo B. Effect of cimetidine on cyclophosphamide-induced liver toxicity in albino rats. Asian J Med Sci. 2018;9(5):50–56.
   Google Scholar
• Xu G, McLeod HL. Strategies for enzyme/prodrug cancer therapy. Clin Cancer Res. 2001;7(11):3314–3324.
   PubMed Web of Science ®Google Scholar
• Zhao G, Rodriguez BL. Molecular targeting of liposomal nanoparticlesto tumor microenvironment. Int J Nanomed. 2013;8:61–71.
   PubMed Web of Science ®Google Scholar
• Cuce G, Cetinkaya S, Koc T, et al. Chemoprotective effect of vitamin E in cyclophosphamide-induced hepatotoxicity in rats. Chem Biol Interact. 2015;232:7–11.
   PubMed Web of Science ®Google Scholar
• Bohnenstengel F, Friedel G, Ritter CA, et al. Variability of cyclophosphamide up-take into human bronchial carcinoma: consequences for local bio activation. Cancer Chemother Pharmacol. 2000;45(1):63–68.
   PubMed Web of Science ®Google Scholar
• Abdel-Hafez SMN, Rifaai RA, Abdelzaher WY. Possible protective effect of royal jelly against cyclophosphamide induced prostatic damage in male albino rats; a biochemical, histological and immuno-histo-chemical study. Biomed Pharmacother. 2017;90:15–23.
   PubMed Web of Science ®Google Scholar
• Zarei M, Shivanandappa T. Amelioration of cyclophosphamide-induced hepatotoxicity by the root extract of Decalepis hamiltonii in mice. Food Chem Toxicol. 2013;57:179–184.
   PubMed Web of Science ®Google Scholar
• Zhu H, Long MH, Wu J, et al. Ginseng alleviates cyclophosphamide-induced hepatotoxicity via reversing disordered homeostasis of glutathione and bile acid. Sci Rep. 2015;5(1):17536.
   PubMedGoogle Scholar
• Muratori L, Ferrari R, Muratori P, et al. Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis. Dig Dis Sci. 2005;50(12):2364–2365.
   PubMed Web of Science ®Google Scholar
• Kim HG, Yoon DH, Lee WH, et al. Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-κB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage. J Ethnopharmacol. 2007;114(3):307–315.
   PubMed Web of Science ®Google Scholar
• Fahmy SR, Amien AI, Abd-Elgleel FM, et al. Antihepatotoxic efficacy of Mangifera indica L. polysaccharides against cyclophosphamide in rats. Chem Biol Interact. 2016;244:113–120.
   PubMed Web of Science ®Google Scholar
• Yang D, Tan X, Lv Z, et al. Regulation of Sirt1/Nrf2/TNF-α signaling pathway by luteolin is critical to attenuate acute mercuric chloride exposure induced hepatotoxicity. Sci Rep. 2016;6(1):37157.
   PubMedGoogle Scholar
• Francis H, Meininger CJ. A review of mast cells and liver disease: what have we learned? Dig Liver Dis J. 2010;42(8):529–536.
   Web of Science ®Google Scholar
• Moreno D, Sobarzo CM, Lustig L, et al. Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord. Asian J Androl. 2019;21:1–6.
   Google Scholar
• El-Haggar SM, Farrag WF, Kotkata FA. Effect of ketotifen in obese patients with type 2 diabetes mellitus. J Diabetes Complications. 2015;29(3):427–432.
   PubMed Web of Science ®Google Scholar
• Reena, Kaur T, Kaur A, Singh M, et al. Mast cell stabilizers obviate high fat diet-induced renal dysfunction in rats. Eur J Pharmacol. 2016;777:96–103.
   PubMed Web of Science ®Google Scholar
• Huang P, Gan X, Liu J, et al. Effects of anti-histamine treatment on liver injury triggered by small intestinal ischemia reperfusion in rats. Chin J Physiol. 2014;57(5):271–278.
   PubMed Web of Science ®Google Scholar
• Fitzgerald JJ, Ustinova E, Koronowski KB, et al. Evidence for the role of mast cells in colon-bladder cross organ sensitization. Auton Neurosci. 2013;173(1–2):6–13.
   PubMed Web of Science ®Google Scholar
• Refaie MMM, Ibrahim SA, Sadek SA, et al. Role of ketotifen in methotrexate-induced nephrotoxicity in rats. Egypt J Basic Clin Pharmacol. 2017;7(2):70–80.
   Google Scholar
• Oyagbemi AA, Omobowale OT, Asenuga ER, et al. Cyclophosphamide-induced hepatotoxicity in Wistar rats: the modulatory role of gallic acid as a hepatoprotective and chemopreventive phytochemical. Int J Prev Med. 2016;7(1):51.
   PubMedGoogle Scholar
• Mansour DF, Saleh DO, Mostafa RE. Genistein ameliorates cyclophosphamide-induced hepatotoxicity by modulation of oxidative stress and inflammatory mediators. OAMJMS. 2017;5(7):836–843.
   Google Scholar
• Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues bythiobarbituric acid test. Anal Biochem. 1978;86:271–278.
   PubMed Web of Science ®Google Scholar
• Sastry K, Moudgal R, Mohan J, et al. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem. 2002;306(1):79–82.
   PubMed Web of Science ®Google Scholar
• Suvarna KS, Layton C, Bancroft JD. 2018. Bancroft’s theory and practice of histological techniques E-Book. New York: Elsevier Health Sciences.
   Google Scholar
• El-Tahawy NF, Ali AH, Saied SR, et al. Effect of glycyrrhizin on lipopolysaccharide/D-galactosamine-induced acute hepatitis in albino rats: a histological and immunohistochemical study. Egypt J Histol. 2011;34(3):518–527.
   Google Scholar
• El‐Tahawy N, Ali A. Possible protective effect of bone marrow‐mesenchymal stem cells (BM‐MSCs) against the remote liver injury induced by renal ischemia reperfusion in male albino rats. J Cytol Histol. 2017;8:1–14.
   Google Scholar
• Subramaniam SR, Cader RA, Mohd R, et al. Low-dose cyclophosphamide-induced acute hepatotoxicity. Am J Case Rep. 2013;14:345.
   PubMedGoogle Scholar
• Aladaileh SH, Abukhalil MH, Saghir SAM, et al. Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of cyclophosphamide-induced hepatotoxicity. Biomolecules. 2019;9:346.
   Web of Science ®Google Scholar
• Santra A, Chowdhury A, Chaudhuri S, et al. Oxidative stress in gastric mucosa in Helicobacter pylori infection. Indian J Gastroenterol. 2000;19(1):21–23.
   PubMedGoogle Scholar
• Ayhanci A, Günes S, Sahinturk V, et al. L-methionine acts on cyclophosphamide-induced kidney toxicity. Biol Trace Elem Res. 2010;136(2):171–179.
   PubMed Web of Science ®Google Scholar
• Jnaneshwari S, Hemshekhar M, Santhosh MS, et al. Crocin, a dietary colorant mitigates cyclophosphamide induced organ toxicity by modulating antioxidant status and inflammatory cytokines. J Pharm Pharmacol. 2013;65(4):604–614.
   PubMed Web of Science ®Google Scholar
• Amien AI, Fahmy SR, Abd-Elgleel FM, et al. Renoprotective effect of Mangifera indica polysaccharides and silymarin against cyclophosphamide toxicity in rats. J Basic Appl Zool. 2015;72:154–162.
   Google Scholar
• Khurana H, Sharma S, Budhiraja RD. Effect of mast cell stabilizer, ketotifen on streptozotocin induced experimental diabetic nephropathy in rats. IJPSR. 2011;2(9):2387–2393.
   Google Scholar
• Zi-Miao C, Lian-Song NI, Mei-Rong W, et al. Effect of ketotifen on oxidative stress of pancreatic beta cells of type 2 diabetic rats. Chin J Pharmacol Toxicol. 2013;27(3):385–390.
   Google Scholar
• Rao AM, Anand U, Anand CV. Myeloperoxidase in chronic kidney disease. Ind J Clin Biochem. 2011;26(1):28–31.
   PubMedGoogle Scholar
• Ameli F, Ciprandi G. Sinerga may prevent recurrent respiratory infections in allergic children. J Biol Regul Homeost Agents. 2019;33(2):601–607.
   PubMed Web of Science ®Google Scholar
• Gu Y, Yang DK, Spinas E, et al. Role of TNF in mast cell neuroinflammation and pain. J Biol Regul Homeost Agents. 2015;29(4):787–791.
   PubMed Web of Science ®Google Scholar
• Jnaneshwari S, Hemshekhar M, Thushara RM, et al. Sesamol ameliorates cyclophosphamide-induced hepatotoxicity by modulating oxidative stress and inflammatory mediators. ACAMC. 2014;14(7):975–983.
   Google Scholar
• Caraffa Al, Gallenga CE, Kritas SK, et al. Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? J Biol Regul Homeost Agents. 2019;33(3):669–673.
   PubMed Web of Science ®Google Scholar
• Gallenga CE, Pandolfi F, Caraffa Al, et al. Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents. 2019;33(1):1–6.
   PubMed Web of Science ®Google Scholar
• Antonopoulos D, Tsilioni I, Balatsos NAA, et al. The mast cell–neurofibromatosis connection. J Biol Regul Homeost Agents. 2019;33(3):657–659.
   PubMed Web of Science ®Google Scholar
• Fragoulis A, Greiber A, Rosen C, et al. ROS as signalling molecule in TNF-α mediated Nrf2 activation in macrophages. Free Radic Biol Med. 2012;53:S48.
   Web of Science ®Google Scholar
• Anoush M, Khani MMR. Advanced pharmaceutical bulletin evaluating the anti-nociceptive and anti-inflammatory effects of ketotifen and fexofenadine in rats. Adv Pharm Bull. 2015;5(2):217–222.
   PubMed Web of Science ®Google Scholar
• Ramos L, Peña G, Cai B, et al. Mast cell stabilization improves survival by preventing apoptosis in sepsis. JI. 2010;185(1):709–716.
   Google Scholar
• Ghisays F, Brace CS, Yackly SM, et al. The N-terminal domain of Sirt1 is a positive regulator of endogenous Sirt1-dependent deacetylation and transcriptional outputs. Cell Rep. 2015;10(10):1665–1673.
   PubMed Web of Science ®Google Scholar
• Huang K, Huang J, Xie X, et al. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Free Radic Biol Med. 2013;65:528–540.
   PubMed Web of Science ®Google Scholar